Bracco argues for PET as preferred cardiac choice
Bracco Diagnostics sees opportunity in the latest decision by the Centers for Medicaid and Medicare Services to reimburse more for PET procedures in 2010.
Bracco Diagnostics sees opportunity in the latest decision by the Centers for Medicaid and Medicare Services to reimburse more for PET procedures in 2010. The final published rule maintains the assignment of all cardiac PET CPT codes to APC 0307 – PET myocardial perfusion imaging – with a 24% increase in payment for the combined radiopharmaceuticals and procedures from $1,156.87 this year to $1,432.87 next. Patient benefits, increased reimbursement, and the worldwide shortage of molybdenum-99 are compelling reasons to implement PET as the preferred choice for myocardial perfusion imaging, according to Kim Giordano, vice president of nuclear medicine at Bracco.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
